Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

FDA, researchers consider first transgenic fish

Article Abstract:

Article discussing how FDA officials are currently considering A/F Protein's application for genetically modified (GM) salmon. If approved by the FDA, the transgenic fish would be the first to make it to market.

Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
Government regulation (cont)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


FDA, researchers consider first transgenic fish

Article Abstract:

Waltham, MA-based A/F Protein has applied to the Food and Drug Administration (FDA) for approval of genetically modified salmon. The transgenic fish has been modified to grow faster and consume less.

Author: niiler, Eric
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
Massachusetts, A/F Protein Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


OECD says industrial biotech not realizing potential

Article Abstract:

Paris, France-based Organization for Economic Cooperation and Development touts biotechnology over chemicals as a manufacturing technique. The environment benefits and it is more cost effective.

Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Brief Article, Genetic engineering, Salmon
Similar abstracts:
  • Abstracts: Financial analysts' earnings forecasts and insider trading. The information content of the auditor's going concern evaluation
  • Abstracts: Europe edges closer to GMO patent harmonization. Biotechnology patents in the food sectors. Agrbiotech and world food security - threat or boon?
  • Abstracts: US public opinion divided over biotechnology? Gene therapy guidelines
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.